Breast cancer cells exploit the TGF-β pathway to promote epithelial-mesenchymal transition (EMT) leading to elevated migratory and invasive characteristics to enhance metastasis to distant sites like the lungs and bones 4, 5. This evidence concerns the gene TGFB1 and breast cancer.